Knockdown of microRNA-21 Inhibits Proliferation and Increases Cell Death by Targeting Programmed Cell Death 4 (PDCD4) in Pancreatic Ductal Adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 15, Issue 1, 2011, Pages 199-208

  Bhatti, Imran ^a   Lee, Andrew ^a   James, Victoria ^a   Hall, Richard I ^a   Lund, Jonathan N ^a   Tufarelli, Cristina ^a   Lobo, Dileep N ^b   Larvin, Michael ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Biomarker; Carcinogenesis; Cell culture; Diagnosis; microRNA; miR 21; Pancreatic cancer or neoplasm or tumour; PDCD4; Prognosis

Indexed keywords

EID: 78751582064     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1381-x     Document Type: Article

References (63)

1. American Gastroenterological Association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology, 1999. 117(6): p. 1463-84.
2. Pitt, H. A., Curative treatment for pancreatic neoplasms. Standard resection. Surg Clin North Am, 1995. 75(5): p. 891-904.
3. Neoptolemos, J. P., et al., Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet, 2001. 358(9293): p. 1576-85.
4. Jemal, A., et al., Cancer statistics, 2005. CA Cancer J Clin, 2005. 55(1): p. 10-30.
5. Richter, A., et al., Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg, 2003. 27(3): p. 324-9.
6. Bae, Y. K. and M. M. Barr, Sensory roles of neuronal cilia: cilia development, morphogenesis, and function in C. elegans. Front Biosci, 2008. 13: p. 5959-74.
7. Bartel, D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004. 116(2): p. 281-97.
8. Dillhoff, M., S. E. Wojcik, and M. Bloomston, MicroRNAs in solid tumors. J Surg Res, 2009. 154(2): p. 349-54.
9. Griffiths-Jones, S., et al., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res, 2006. 34(Database issue): p. D140-4.
10. Bushati, N. and S. M. Cohen, microRNA functions. Annu Rev Cell Dev Biol, 2007. 23: p. 175-205.
11. Schickel, R., et al., MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene, 2008. 27(45): p. 5959-74.
12. He, L., et al., A microRNA polycistron as a potential human oncogene. Nature, 2005. 435(7043): p. 828-33.
13. Ryu, J. K., et al., Aberrant microRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology, 2010. 10(1): p. 66-73.
14. du Rieu, M. C., et al., MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. Clin Chem, 2010. 56(4): p. 603-12.
15. Calin, G. A. and C. M. Croce, MicroRNA signatures in human cancers. Nat Rev Cancer, 2006. 6(11): p. 857-66.
16. Stahlhut Espinosa, C. E. and F. J. Slack, The role of microRNAs in cancer. Yale J Biol Med, 2006. 79(3-4): p. 131-40.
17. Chan, J. A., A. M. Krichevsky, and K. S. Kosik, MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 2005. 65(14): p. 6029-33.
18. Ribas, J., et al., miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res, 2009. 69(18): p. 7165-9.
19. Meng, F., et al., Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology, 2006. 130(7): p. 2113-29.
20. Yao, Q., et al., MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun, 2009. 388(3): p. 539-42.
21. Frankel, L. B., et al., Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem, 2008. 283(2): p. 1026-33.
22. Meng, F., et al., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 2007. 133(2): p. 647-58.
23. Zhu, S., et al., MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem, 2007. 282(19): p. 14328-36.
24. Gabriely, G., et al., MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol, 2008. 28(17): p. 5369-80.
25. Lankat-Buttgereit, B. and R. Goke, The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell, 2009. 101(6): p. 309-17.
26. Jansen, A. P., et al., Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther, 2004. 3(2): p. 103-10.
27. Ma, G., et al., [Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2005. 27(5): p. 597-600.
28. Selaru, F. M., et al., MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology, 2009. 49(5): p. 1595-601.
29. Asangani, I. A., et al., MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 2008. 27(15): p. 2128-36.
30. Chen, Y., et al., MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett, 2008. 272(2): p. 197-205.
31. Ding, J., et al., Gain of miR-151 on chromosome 8q24. 3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol, 2010. 12(4): p. 390-9.
32. Bloomston, M., et al., MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 2007. 297(17): p. 1901-8.
33. Zhang, Y., et al., Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg, 2009. 33(4): p. 698-709.
34. Ambion, I. TRI Reagent Solution: RNA/DNA/Protein Isolation Reagent. 2008 [cited; Available from: http://www. ambion. com/techlib/prot/bp_9738. pdf].
35. Dharmacon, T. S. miRIDIAN microRNA Mimics, Hairpin Inhibitors and Negative Controls. 2010 [cited; Available from: http://www. dharmacon. com/product/productlandingtemplate. aspx?id=281].
36. ueousNon-Radioactive Cell Proliferation Assay. 2009 [cited; Available from: http://www. promega. com/tbs/tb169/tb169. html].
37. Merck. QIA20 Cell Death Detection (Nuclear Matrix Protein) ELISA Kit Protocol. 2009 [cited; Available from: http://www. merck-chemicals. com/life-science-research/cell-death-detection-nuclear-matrix-protein-elisa-kit/EMD_BIO-QIA20/p_uLGb. s1O98sAAAEnlo85SfM4].
38. Bhatti, I., et al., Small RNA: a large contributor to carcinogenesis? J Gastrointest Surg, 2009. 13(7): p. 1379-88.
39. Fabbri, M., et al., MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia, 2008. 22(6): p. 1095-105.
40. Chen, Y., et al., Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg, 2010. 14: p. 1170-9.
41. Srinivasan, M., D. Sedmak, and S. Jewell, Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol, 2002. 161(6): p. 1961-71.
42. Cronin, M., et al., Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol, 2004. 164(1): p. 35-42.
43. Li, J., et al., Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol, 2007. 7: p. 36.
44. Wang, B., et al., TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene, 2010. 29(12): p. 1787-97.
45. Zhu, W., et al., miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer, 2010.
46. James, T. A., et al., Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer, 2004. 101(12): p. 2722-6.
47. Farma, J. M., et al., PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol, 2008. 15(9): p. 2465-71.
48. Dillhoff, M., et al., MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg, 2008. 12: p. 2171-6.
49. Kloosterman, W. P. and R. H. Plasterk, The diverse functions of microRNAs in animal development and disease. Dev Cell, 2006. 11(4): p. 441-50.
50. Grimson, A., et al., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell, 2007. 27(1): p. 91-105.
51. Chen, X., et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008. 18(10): p. 997-1006.
52. Mitchell, P. S., et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 2008. 105(30): p. 10513-8.
53. Szafranska, A. E., et al., Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin Chem, 2008. 54(10): p. 1716-24.
54. Wang, J., et al., MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila Pa), 2009. 2(9): p. 807-13.
55. Si, M. L., et al., miR-21-mediated tumor growth. Oncogene, 2007. 26(19): p. 2799-803.
56. Corsten, M. F., et al., MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res, 2007. 67(19): p. 8994-9000.
57. Schetter, A. J., et al., Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res, 2009. 15(18): p. 5878-87.
58. Feber, A., et al., MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg, 2008. 135(2): p. 255-60; discussion 260.
59. Chan, S. H., et al., miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res, 2008. 28(2A): p. 907-11.
60. Moriyama, T., et al., MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther, 2009. 8: p. 1067-74.
61. Motoyama, K., et al., Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol, 2010. 36(5): p. 1089-95.
62. Mathe, E. A., et al., MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res, 2009. 15(19): p. 6192-200.
63. Tsukamoto, Y., et al., MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res, 2010. 70(6): p. 2339-49.